Early signals from environmental filings in India and China
See who is adding, cutting or backward-integrating API capacity before it shows up in DMF lists.
Plants in India and China need environmental approval before they build or change their product mix. Those filings list molecules and tonnes. We read them and turn them into molecule-level signals.
Every signal links to the source filing. Clearance is not production: we show the stage, you judge the timing.
Three kinds of signal
New molecule or more tonnes at a plant
Tells API sellers who is entering their molecule, and buyers where a new source may appear in 1–3 years.
Example: rivaroxaban added at two Indian sites in 2025–2026; Aurisco adds eplerenone 60 t/yr on new lines in Zhejiang in 2026.
Molecule dropped or clearance surrendered
Tells buyers to qualify a second source now, not after shipments stop.
Example: mefenamic acid removed from a Nashik plant in 2026; a Zhejiang plant cuts gabapentin from 1,800 to 850 t/yr.
Plant starts making its own KSMs
A shorter, less China-exposed supply chain behind the API you already buy.
Example: IPCA files for 3,480 t/yr of losartan and valsartan intermediates.
Latest signals
All signals →| Filing | Molecule | Signal | Plant | Stage | t / year |
|---|---|---|---|---|---|
| Nov 2026 | Amlodipine besylate | ↑ NEW AT SITE | Zhejiang Huahai Jiancheng Pharmaceutical Co., Ltd.Taizhou Bay Economic and Technological Development Zone, Zhejiang | EIA approved | +140 |
| Nov 2026 | Sacubitril sodium | ↑ NEW AT SITE | Zhejiang Huahai Jiancheng Pharmaceutical Co., Ltd.Taizhou Bay Economic and Technological Development Zone, Zhejiang | EIA approved | +20 |
| Nov 2026 | Sacubitril/valsartan sodium | ↑ NEW AT SITE | Zhejiang Huahai Jiancheng Pharmaceutical Co., Ltd.Taizhou Bay Economic and Technological Development Zone, Zhejiang | EIA approved | +40 |
| Nov 2026 | Sertraline hydrochloride | ↑ NEW AT SITE | Zhejiang Huahai Jiancheng Pharmaceutical Co., Ltd.Taizhou Bay Economic and Technological Development Zone, Zhejiang | EIA approved | +70 |
| Oct 2026 | 85 molecules in one filing | ↑ NEW PLANT | Nanoarray Biosciences Pvt. Ltd.Ahmedabad, Gujarat | Public hearing held | — |
| Oct 2026 | Dydrogesterone | ↑ CAPACITY UP | Zhejiang Shenzhou Pharmaceutical Co., Ltd.Taizhou, Zhejiang | EIA approved | +2 |
| Sep 2026 | Whole site | ↑ NEW PLANT | Arhanth Bio CDMO Pvt. Ltd.Surat, Gujarat | Public hearing held | +60 |
| Sep 2026 | Whole site | ↑ NEW AT SITE | Bhakti Pharmaceuticals Pvt. Ltd.Rajkot, Gujarat | Public hearing held | +240 |
Sample: 226 signals from filings dated February 2025 – November 2026. Each molecule page links to the original documents.
Molecules with recent activity
Browse A–Z →Watch a company
See every molecule a competitor or supplier has added, cut or integrated, plant by plant. Example: Sai Life Sciences added 22 products and removed 9 at its Bidar unit in one filing.
Browse companiesKnow what is coming. Then find who makes it today.
Current manufacturers for every molecule, with US DMF and CEP status, plant addresses and contacts, in the api-fdf.com database.
How we read filings
Each signal carries its stage. The earlier the stage, the further out the capacity.
- STEP 1Terms of referencePlan announced, product list filed
- STEP 2Public hearingFull EIA with tonnes per molecule
- STEP 3Environmental clearancePermission to build or change mix
- STEP 4Consent to operatePlant may start production
- STEP 5DMF / CEP filedSupplier visible to regulated markets
In China the steps are: EIA filed for review → approval notice → EIA approved → completion check → DMF / CEP.
Monthly signal digest
New capacity, exits and integration moves in one email. Tell us which molecules you watch.